Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Mortimer

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|September 7, 2014
The effect of formulation and food consumption on the bioavailability of dovitinib (TKI258) in patients with advanced solid tumorsSunil Sharma, Carolyn D Britten, Joanne Mortimer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providersArti Hurria, F Lennie Wong, Doojduen Villaluna, et al.
BMC Cancer|October 2, 2012
Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancerSumanta K Pal, Mary Dehaven, Rebecca A Nelson, et al.
Breast Cancer Research and Treatment|May 28, 2026
Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution studyAlexis LeVee, Bethania Santos, Megan Wong, et al.
Breast Cancer Research and Treatment|June 26, 2019
Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot studyKyuwan Lee, Irene Kang, Wendy J Mack, et al.
Scientific Reports|May 19, 2019
Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancerYuan Yuan, Wei Wen, Susan E Yost, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2023
Bilateral Oophorectomy and Colorectal Cancer Incidence and Mortality in the Women's Health InitiativeMihae Song, Rebecca A Nelson, Laura Kruper, et al.
Annals of Surgical Oncology|January 23, 2020
Insurance Status Predicts Survival in Women with Breast Cancer: Results of Breast and Cervical Cancer Treatment Program in CaliforniaRebecca A Nelson, Zeynep Bostanci, Veronica Jones, et al.
Breast Cancer Research and Treatment|September 10, 2024
Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health InitiativeRebecca A Nelson, Rowan T Chlebowski, Kathy Pan, et al.
Cancer Investigation|November 5, 2015
A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid MalignanciesSam Joseph Lubner, Jacqueline Mullvain, Scott Perlman, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|September 7, 2014
The effect of formulation and food consumption on the bioavailability of dovitinib (TKI258) in patients with advanced solid tumorsSunil Sharma, Carolyn D Britten, Joanne Mortimer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providersArti Hurria, F Lennie Wong, Doojduen Villaluna, et al.
BMC Cancer|October 2, 2012
Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancerSumanta K Pal, Mary Dehaven, Rebecca A Nelson, et al.
Breast Cancer Research and Treatment|May 28, 2026
Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution studyAlexis LeVee, Bethania Santos, Megan Wong, et al.
Breast Cancer Research and Treatment|June 26, 2019
Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot studyKyuwan Lee, Irene Kang, Wendy J Mack, et al.
Scientific Reports|May 19, 2019
Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancerYuan Yuan, Wei Wen, Susan E Yost, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2023
Bilateral Oophorectomy and Colorectal Cancer Incidence and Mortality in the Women's Health InitiativeMihae Song, Rebecca A Nelson, Laura Kruper, et al.
Annals of Surgical Oncology|January 23, 2020
Insurance Status Predicts Survival in Women with Breast Cancer: Results of Breast and Cervical Cancer Treatment Program in CaliforniaRebecca A Nelson, Zeynep Bostanci, Veronica Jones, et al.
Breast Cancer Research and Treatment|September 10, 2024
Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health InitiativeRebecca A Nelson, Rowan T Chlebowski, Kathy Pan, et al.
Cancer Investigation|November 5, 2015
A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid MalignanciesSam Joseph Lubner, Jacqueline Mullvain, Scott Perlman, et al.
Pageof 11